| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GLYC | Common Stock | Sale | -$3.52K | -3.23K | -1% | $1.09 | 321K | Mar 9, 2022 | Direct | F1, F2 |
| holding | GLYC | Common Stock | 4.85K | Mar 9, 2022 | By GlycoTech Corporation | F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected to satisfy tax withholding obligations in connection with the settlement of restricted stock units as part of a "sell to cover" transaction and do not represent discretionary trades by the reporting person. |
| F2 | The common stock was sold by the reporting person in a series of open market transactions on the transaction date with a volume weighted average sale price of $1.09. The range of sales prices for the transactions reported was $1.09 to $1.10 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder. |